Wednesday, September 6, 2017

Bone Marrow Transplantation - Table of Contents alert Volume 52 Issue 9

If you are unable to see the message below, click here to view.
Bone Marrow Transplantation
TABLE OF CONTENTS

Volume 52, Issue 9 (September 2017)

In this issue
Reviews
Special Report
Original Articles
Letters to the Editor

Also new
AOP
 
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Reviews

Top

Tregs: hype or hope for allogeneic hematopoietic stem cell transplantation?

F Lussana, M Di Ianni and A Rambaldi

Bone Marrow Transplant 2017 52: 1225-1232; advance online publication, March 20, 2017; 10.1038/bmt.2017.30

Abstract | Full Text

In search of the optimal platform for Post-Allogeneic SCT immunotherapy in relapsed multiple myeloma: a systematic review

R Oostvogels, S M Uniken Venema, M de Witte, R Raymakers, J Kuball, N Kröger and M C Minnema

Bone Marrow Transplant 2017 52: 1233-1240; advance online publication, July 10, 2017; 10.1038/bmt.2017.141

Abstract | Full Text

Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future OPEN

A Saad and L S Lamb

Bone Marrow Transplant 2017 52: 1241-1248; advance online publication, March 20, 2017; 10.1038/bmt.2017.22

Abstract | Full Text

Special Report

Top

First experience of hematopoietic stem cell transplantation treatment of Shwachman–Diamond syndrome using unaffected HLA–matched sibling donor produced through preimplantation HLA typing OPEN

A A Isaev, R V Deev, A Kuliev, I L Plaxa, N V Stancheva, A S Borovkova, I V Potapov, E A Pomerantseva, A G Chogovadze, K Y Boyarsky, A E Semenenko, A V Mikhailov, K G Shevchenko, A V Prikhodko, S Rechitsky, O V Paina, I M Barchatov, L S Zubarovskaya, O Verlinsky, I Y Bozo and B V Afanasyev

Bone Marrow Transplant 2017 52: 1249-1252; advance online publication, March 27, 2017; 10.1038/bmt.2017.46

Abstract | Full Text

Original Articles

Top

ACUTE LEUKEMIA

Idarubicin-intensified haploidentical HSCT with GvHD prophylaxis of ATG and basiliximab provides comparable results to sibling donors in high-risk acute leukemia

R Zhang, W Shi, H-F Wang, Y You, Z-D Zhong, W-M Li, C Zhang, X Lu, Y-D Wang, P Zheng, J Fang, M Hong, Q-L Wu and L-H Xia

Bone Marrow Transplant 2017 52: 1253-1260; advance online publication, June 5, 2017; 10.1038/bmt.2017.100

Abstract | Full Text

GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia

S Terakura, Y Kuwatsuka, S Yamasaki, A Wake, J Kanda, Y Inamoto, S Mizuta, T Yamaguchi, N Uchida, Y Kouzai, N Aotsuka, H Ogawa, H Kanamori, K Nishiwaki, S Miyakoshi, M Onizuka, I Amano, T Fukuda, T Ichinohe, Y Atsuta, M Murata and T Teshima for The Japan Society for Hematopoietic Cell Transplantation GVHD working group

Bone Marrow Transplant 2017 52: 1261-1267; advance online publication, June 12, 2017; 10.1038/bmt.2017.116

Abstract | Full Text

LYMPHOMA

High-dose chemotherapy and autologous stem cell transplantation for primary central nervous system lymphoma: a multi-centre retrospective analysis from the United Kingdom

S Kassam, E Chernucha, A O’Neill, C Hemmaway, T Cummins, S Montoto, A Lennard, G Adams, K Linton, P McKay, D Davies, C Rowntree, S Easdale, T A Eyre, R Marcus, K Cwynarski and C P Fox

Bone Marrow Transplant 2017 52: 1268-1272; advance online publication, June 5, 2017; 10.1038/bmt.2017.101

Abstract | Full Text

GRAFT SOURCE

Single-agent GvHD prophylaxis with tacrolimus after post-transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies

A Esquirol, M J Pascual, M Ortiz, J L Piñana, C Ferra, I Garcia Cadenas, I Vilades, S Brunet, R Martino and J Sierra

Bone Marrow Transplant 2017 52: 1273-1279; advance online publication, June 12, 2017; 10.1038/bmt.2017.111

Abstract | Full Text

HISTOCOMPATIBILITY AND DONOR SELECTION ISSUES

Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation

K Fleischhauer, K W Ahn, H L Wang, L Zito, P Crivello, C Müller, M Verneris, B E Shaw, J Pidala, M Oudshorn, S J Lee and S R Spellman

Bone Marrow Transplant 2017 52: 1280-1287; advance online publication, June 5, 2017; 10.1038/bmt.2017.96

Abstract | Full Text

TRANSPLANT TOXICITIES

An individualised risk-adapted protocol of pre- and post transplant zoledronic acid reduces bone loss after allogeneic stem cell transplantation: results of a phase II prospective trial

A Grigg, B Butcher, B Khodr, A Bajel, M Hertzberg, S Patil, A B D'Souza, P Ganly, P Ebeling and E Wong on behalf of the Australasian Leukaemia and Lymphoma Group (ALLG)

Bone Marrow Transplant 2017 52: 1288-1293; advance online publication, June 19, 2017; 10.1038/bmt.2017.108

Abstract | Full Text

The burden of chemotherapy-induced nausea and vomiting in children receiving hematopoietic stem cell transplantation conditioning: a prospective study

J Flank, J Sparavalo, H Vol, L Hagen, R Stuhler, D Chong, S Courtney, J J Doyle, A Gassas, T Schechter and L L Dupuis

Bone Marrow Transplant 2017 52: 1294-1299; advance online publication, June 5, 2017; 10.1038/bmt.2017.112

Abstract | Full Text

GRAFT-VERSUS-HOST DISEASE

Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402

S G Holtan, L F Newell, C Cutler, M R Verneris, T E DeFor, J Wu, A Howard, M L MacMillan, J H Antin, B R Blazar, D J Weisdorf and A Panoskaltsis-Mortari

Bone Marrow Transplant 2017 52: 1300-1303; advance online publication, June 5, 2017; 10.1038/bmt.2017.89

Abstract | Full Text

Low incidence of severe cGvHD and late NRM in a phase II trial of thymoglobulin, tacrolimus and sirolimus for GvHD prevention

Z Al-Kadhimi, Z Gul, M Abidi, L G Lum, A Deol, W Chen, H Jang, C Ozust, A Langston, E Waller and J Uberti

Bone Marrow Transplant 2017 52: 1304-1310; advance online publication, June 5, 2017; 10.1038/bmt.2017.95

Abstract | Full Text

Elevated bone marrow eosinophil count is associated with high incidence of severe acute GvHD after allogeneic hematopoietic stem cell transplantation

Y Shimomura, M Hara, H Hashimoto and T Ishikawa

Bone Marrow Transplant 2017 52: 1311-1316; advance online publication, June 19, 2017; 10.1038/bmt.2017.98

Abstract | Full Text

Endothelial damage is aggravated in acute GvHD and could predict its development

E Mir, M Palomo, M Rovira, A Pereira, G Escolar, O Penack, E Holler, E Carreras and M Diaz-Ricart

Bone Marrow Transplant 2017 52: 1317-1325; advance online publication, June 26, 2017; 10.1038/bmt.2017.121

Abstract | Full Text

Letters to the Editor

Top

Toxoplasmosis disease in paediatric hematopoietic stem cell transplantation: do not forget it still exists

N Decembrino, A Comelli, F Genco, A Vitullo, S Recupero, M Zecca and V Meroni

Bone Marrow Transplant 2017 52: 1326-1329; advance online publication, June 12, 2017; 10.1038/bmt.2017.117

Full Text

Extracorporeal life support survival in a pediatric hematopoietic cellular transplant recipient with presumed GvHD-related fulminant myocarditis OPEN

M S Zinter, B D Barrows, P C Ursell, K Kowalek, K Kalantar, N Cambronero, J L DeRisi, P Oishi and C C Dvorak

Bone Marrow Transplant 2017 52: 1330-1333; advance online publication, June 5, 2017; 10.1038/bmt.2017.114

Full Text

Development of quality of life in patients undergoing allogeneic stem cell transplantation with regard to anxiety, depression and resilience

A Schumacher, C Sauerland, G Silling, W E Berdel, M Stelljes and R Koch

Bone Marrow Transplant 2017 52: 1334-1337; advance online publication, June 26, 2017; 10.1038/bmt.2017.123

Full Text

Parent versus child donor perceptions of the bone marrow donation experience

G E Switzer, J Bruce, G Pastorek, D M Kiefer, H Kobusingye, R Drexler, R A M Besser, D L Confer, M M Horowitz, R J King, B E Shaw, S M van Walraven, L Wiener, W Packman, J W Varni and M A Pulsipher

Bone Marrow Transplant 2017 52: 1338-1341; advance online publication, June 26, 2017; 10.1038/bmt.2017.124

Full Text

Pre-autologous transplantation PET/CT using Deauville criteria is an independent predictor of progression in relapsed refractory classical Hodgkin lymphoma

M Damlaj, S Ghazi, G Syed, T Pasha, G Gmati, H Salama, O Ali, K A Abuelgasim, M Al-Zahrani, A Hejazi and A Al Askar

Bone Marrow Transplant 2017 52: 1342-1344; advance online publication, July 10, 2017; 10.1038/bmt.2017.143

Full Text

No report on Zika virus infection in EBMT registry: Infectious Diseases Working Party statement

J Styczynski, J Hoek, N Knelange, M Mikulska, S Cesaro, M Aljurf and L Gil

Bone Marrow Transplant 2017 52: 1345-1346; advance online publication, July 10, 2017; 10.1038/bmt.2017.145

Full Text

HLA-mismatched bone marrow transplantation in severe aplastic anemia

L S Bachegowda, M V Shah, L W Veltri, A Tanase, U Popat, P Anderlini, J Chen, G Rondon, R E Champlin and S O Ciurea

Bone Marrow Transplant 2017 52: 1347-1348; advance online publication, July 10, 2017; 10.1038/bmt.2017.146

Full Text

The incidence of atrial fibrillation among patients with AL amyloidosis undergoing high-dose melphalan and stem cell transplantation: experience at a single institution

M Arun, D Brauneis, G Doros, A C Shelton, J M Sloan, K Quillen, F L Ruberg, V Sanchorawala and C Varga

Bone Marrow Transplant 2017 52: 1349-1351; advance online publication, July 24, 2017; 10.1038/bmt.2017.148

Full Text

JACIE accreditation from the perspective of an accredited centre

C Boga and I Kozanoglu

Bone Marrow Transplant 2017 52: 1352; advance online publication, July 10, 2017; 10.1038/bmt.2017.149

Full Text

Cord blood attached segment: is this a relevant quality control to predict a good hematopoietic stem cell graft?

L Faivre, H Boucher, R Zerbib, T Domet, A Desproges, C Couzin, V Vanneaux, J Larghero and A Cras

Bone Marrow Transplant 2017 52: 1353-1354; advance online publication, July 10, 2017; 10.1038/bmt.2017.150

Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature
 

No comments: